Alteogen Inc. Logo

Alteogen Inc.

Biotech firm developing next-gen ADCs and biobetters with proprietary platform technologies.

196170 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
대전광역시 유성구 유성대로1628번길 62 (전민동 461-38번지), 대전광역시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Alteogen Inc. is a biotechnology company focused on the research and development of next-generation biopharmaceuticals, including long-acting biobetters, antibody-drug conjugates (ADCs), and biosimilars. The company leverages a portfolio of proprietary platform technologies to improve existing biologic therapies. Its core technologies include Hybrozyme™, which enables the conversion of intravenous formulations to subcutaneous injections for enhanced patient convenience; NexP™ Fusion, a technology for creating long-acting biologics; and NexMab™, an ADC platform designed for superior stability and efficacy. Through these innovations, Alteogen aims to deliver therapies with enhanced efficacy, durability, and safety profiles.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-10 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.7 KB
2025-08-13 00:00
Interim Report
반기보고서 (2025.06)
Korean 2.1 MB
2025-05-21 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-05-13 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 2.1 MB
2025-04-30 00:00
Regulatory News Service
소속부변경
Korean 3.6 KB
2025-04-03 00:00
M&A Activity
회사합병결정(종속회사의주요경영사항)
Korean 19.8 KB
2025-04-03 00:00
M&A Activity
타법인주식및출자증권취득결정
Korean 16.6 KB
2025-04-03 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 117.7 KB
2025-03-31 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 25.6 KB
2025-03-31 00:00
Share Issue/Capital Change
주식매수선택권부여에관한신고
Korean 15.1 KB
2025-03-26 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.7 KB
2025-03-21 00:00
Audit Report / Information
감사보고서제출
Korean 25.1 KB
2025-03-21 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 583.5 KB
2025-03-17 00:00
Regulatory News Service
투자판단관련주요경영사항 (인간 히알루로니다제 원천 기술(ALT-B4) 독점적 라이선스 계약 체결)
Korean 11.2 KB
2025-03-17 00:00
Regulatory News Service
투자판단관련주요경영사항 (인간 히알루로니다제 원천 기술(ALT-B4) 독점적 라이선스 계약 체결)
Korean 11.2 KB

Automate Your Workflow. Get a real-time feed of all Alteogen Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Alteogen Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.